Literature DB >> 7741215

Microheterogeneity of erythropoietin carbohydrate structure.

R S Rush1, P L Derby, D M Smith, C Merry, G Rogers, M F Rohde, V Katta.   

Abstract

The microheterogeneity of the carbohydrate structures on recombinant human erythropoietin (rHuEPO) expressed in Chinese hamster ovary cells has been evaluated by electrospray ionization (ESI) mass spectrometry (MS) of glycopeptide fragments. The microheterogeneity is largely associated with the presence or absence of terminal N-acetylneuraminic acid (Neu5Ac) residues, varying amounts of O-acetylation of the Neu5Ac residues, and the presence or absence of N-acetyllactosamine extensions. The N-linked carbohydrate structures were structurally diverse; 52 different N-linked oligosaccharide structures were identified. Consistent structural assignments could be made from data obtained using different proteolytic digests, ESI solvent systems (aqueous/methanol systems with acetic or formic acid), and on-line or off-line LC/MS analysis. All glycosylation sites exhibited some level of O-acetylation of Neu5Ac residues. Interestingly, glycosylation site asparagine-83 exhibits mono-O-acetyl and di-O-acetyl Neu5Ac residues, while the other sites, asparagine-24, asparagine-38, and serine-126, exhibit mainly mono-O-acetyl Neu5Ac derivatization. This difference in O-acetylation may be site specific or due to sample handling of labile structures. However, mild base treatment of rHuEPO with NaOH on ice removed the O-acetyl groups associated with a given carbohydrate structure, without adversely affecting the underlying oligosaccharide structure, resulting in a simplified mass spectra. Nuclear magnetic resonance spectroscopy of Neu5Ac residues released by neuraminidase treatment of total rHuEPO indicated that Neu5,9Ac2 residues were present. Additional resonances were also observed that were consistent with other Neu5Ac O-acetyl linkages; these O-acetyl resonances could be removed by mild base hydrolysis of rHuEPO.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7741215     DOI: 10.1021/ac00104a022

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  16 in total

1.  Analysis of glycoprotein heterogeneity by capillary electrophoresis and mass spectrometry.

Authors:  A D Hooker; D C James
Journal:  Mol Biotechnol       Date:  2000-03       Impact factor: 2.695

2.  An innovative approach for the characterization of the isoforms of a monoclonal antibody product.

Authors:  Shanmuuga Sundaram; Alice Matathia; Jun Qian; Jingming Zhang; Ming-Ching Hsieh; Tun Liu; Richard Crowley; Babita Parekh; Qinwei Zhou
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

3.  Analysis of recombinat glycoproteins by mass spectrometry.

Authors:  D C James
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

4.  Erythropoietin and blood doping.

Authors:  N Robinson; S Giraud; C Saudan; N Baume; L Avois; P Mangin; M Saugy
Journal:  Br J Sports Med       Date:  2006-07       Impact factor: 13.800

Review 5.  Emerging erythropoiesis-stimulating agents.

Authors:  Robert N Foley
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

6.  Erythropoietin derived by chemical synthesis.

Authors:  Ping Wang; Suwei Dong; Jae-Hung Shieh; Elizabeth Peguero; Ronald Hendrickson; Malcolm A S Moore; Samuel J Danishefsky
Journal:  Science       Date:  2013-12-13       Impact factor: 47.728

Review 7.  Generic Substitution of Orphan Drugs for the Treatment of Rare Diseases: Exploring the Potential Challenges.

Authors:  Antonello Di Paolo; Elena Arrigoni
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

8.  Development of an in vitro Bioassay for Recombinant Human Erythropoietin (rHuEPO) Based on Proliferative Stimulation of an Erythroid Cell Line and Analysis of Sialic Acid Dependent Microheterogeneity: UT-7 Cell Bioassay.

Authors:  Manoj Kumar Metta; Vasavi Malkhed; Srinivasan Tantravahi; Uma Vuruputuri; Rajkumar Kunaparaju
Journal:  Protein J       Date:  2017-04       Impact factor: 2.371

Review 9.  Biosimilar erythropoiesis-stimulating agents and the risk of developing anti-drug antibodies-a systematic review.

Authors:  Marianne Heibert Arnlind; Linda Fryklund; Sigurd Vitols; Göran Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2016-07-21       Impact factor: 2.953

Review 10.  Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.

Authors:  S Elliott
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.